
Mdrabe D 30mg/20mg Capsule SR
Marketer
Medicamento Pharma
Salt Composition
Domperidone (30mg) + Rabeprazole (20mg)
Overview Mdrabe D 30mg/20mg Capsule SR
Gastroesophageal reflux disease (GERD, or acid reflux) can be managed with the combined-action medication, Mdrabe D 30mg/20mg Sustained-Release Capsules. This formulation targets acid reflux symptoms like heartburn, abdominal pain, and irritation by neutralizing stomach acid and facilitating gas expulsion for enhanced comfort. Mdrabe D 30mg/20mg SR Capsules should be taken on an empty stomach, following your physician's prescribed dosage and regimen. Treatment duration is determined by your individual response and condition. Premature discontinuation may lead to symptom recurrence and potential worsening of your condition. Always inform your healthcare provider of all other medications you're using, as interactions may occur. Common side effects include diarrhea, abdominal discomfort, dry mouth, headache, gas, and fatigue; most are transient and resolve spontaneously. Report any concerning side effects promptly to your doctor. Due to potential drowsiness and dizziness, avoid driving or activities requiring alertness until the medication's effects are known. Alcohol consumption should be avoided as it can exacerbate drowsiness. Lifestyle adjustments such as consuming cool milk and avoiding caffeine, spicy foods, and chocolate may improve outcomes. Prior to commencing treatment, disclose any kidney or liver conditions, as well as pregnancy, pregnancy planning, or breastfeeding to your doctor.
Primary Ingredients of Mdrabe D 30mg/20mg Capsule SR
No text provided to rephrase.
Uses of Mdrabe D 30mg/20mg Capsule SR
Managing gastroesophageal reflux and peptic ulcers.
Major Benefits of Mdrabe D 30mg/20mg Capsule SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the entire capsule whole; avoid chewing, crushing, or fracturing it. Administer Mdrabe D 30mg/20mg Extended-Release Capsules on an empty stomach.
Common Side effects of Mdrabe D 30mg/20mg Capsule SR:
- Cough
- Headache
- Diarrhea
- Dizziness
- Inflammation of the nose
- Abdominal pain
- Vomiting
- Weakness
- Nasal congestion (stuffy nose)
- Insomnia (difficulty in sleeping)
- Fundic gland polyps
- Nausea
- Constipation
- Flatulence
- Back pain
- Pharyngitis
How to use Mdrabe D 30mg/20mg Capsule SR:
Consume this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment period. Ingest the entire capsule; avoid chewing, crushing, or breaking it. Mdrabe D 30mg/20mg Sustained-Release Capsules should be taken on an empty stomach.
How Mdrabe D 30mg/20mg Capsule SR works:
Mdrabe D SR capsules (30mg/20mg Domperidone/Rabeprazole) combine a prokinetic agent, Domperidone, with a proton pump inhibitor (PPI), Rabeprazole. Domperidone enhances upper gastrointestinal motility, facilitating smoother food passage. Rabeprazole decreases stomach acid production, providing relief from heartburn and acid indigestion.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when drinking alcohol while taking Mdrabe D 30mg/20mg SR capsules. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
The extended-release capsule Mdrabe D (30mg/20mg) may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing this medication. Patient consultation with their doctor is advised.
Breast feedingCONSULT YOUR DOCTOR
The extended-release capsule Mdrabe D 30mg/20mg is likely unsafe for breastfeeding mothers. Available human data indicates potential drug transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking Mdrabe D 30mg/20mg sustained-release capsules could reduce attentiveness, impair vision, and cause drowsiness or dizziness. Refrain from driving if these effects are experienced.
KidneyCAUTION
Individuals with impaired kidney function should exercise caution when using Mdrabe D 30mg/20mg sustained-release capsules. Dosage modification of Mdrabe D 30mg/20mg sustained-release capsules may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Mdrabe D 30mg/20mg sustained-release capsules cautiously, potentially requiring dosage modification. Consult a physician for guidance. Mdrabe D 30mg/20mg sustained-release capsules are contraindicated for individuals with moderate to severe hepatic dysfunction.
What if you forget to take Mdrabe D 30mg/20mg Capsule SR :
Should you forget to take a Mdrabe D 30mg/20mg Capsule SR, ingest it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Mdrabe D 30mg/20mg Capsule SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal System |
